TURP (transurethral resection of the prostate)
Occasionally, surgery is required to remove part of or the entire tumor around a man's uretha. The uretha is the tube that transports urine from the bladder. An operation that takes away some of the cancer that is causing the symptoms may be suggested by the doctor, although this operation is not always performed to cure the cancer. It can, in fact just relieve the symptoms which are caused by the tumour pressing on the uretha. An example of such a symptom is the inability to empty the bladder properly. The most performed surgery is a TUR or TURP which stands for 'transurethral resection of the prostate.'
A TUR is performed by inserting a thin tube into the uretha via the penis. The tube contains a telescope allowing the surgeon to view inside the uretha. Any blockage is removed using an instrument which is attached to the telescope. A patient is expected to spend two to three nights in hospital post surgery.
A TUR is usually performed under a general anaesthetic although some men have a spinal anaestetic, known as an epidural. This means that he remains awake but is unable to feel anything. An epidural may be suggested if the doctor believes that there are any reasons why the man should not have a general anaestetic, for example, unhealthy lungs or heart.
It is advised to begin moving around as much as possible following the operation and most men find that they are up and about within approximately 24 hours.
Many men have an intravenous infusion (drip) to replace the body fluids. This can be removed once normal drinking resumes as it is very important to drink plenty of fluids.
Many patients have a catheter in situ which is a tube going into the bladder to drain urine into a bag. It is perfectly normal to find blood clots in the urine following this type of surgery and bladder irregation is often used to prevent any blood clots blocking the catheter. This involves the passing of fluid into the bladder which is then drained out of the catheter. You will note that the blood in the urine will clear slowly before the catheter can be removed, normally over two or three days post surgery. It is important to advise your doctor/nurse once you pass urine following the removal of the catheter.
Many men find that they are unable to pass urine once their catheter has been removed. This is often due to swelling around the neck of the bladder and the prostate. You may have the catheter reinserted if you are unable to pass urine. Another attempt to urinate without the catheter will be made in a day or two.
Some men have to keep their catheter in situ after they have gone home. Before discharge from hospital, the nurse will show the patient how to maintain the catheter and a district nurse will be arranged to help with any problems at home. If a patient belives he will experience difficulties coping at home, the nurse or a social worker should be notified so help can be arranged.
An appointment will be made to visit the out patient clinic for a check up approximately six weeks later. Problems you may be experiencing can also be discussed.
Pain and discomfort will be experienced for a few days post surgery although there are a number of painkillling drugs available. This should be discussed with the doctor/nurse, especially if the pain continues.
Prostate cancer news on the Web
Prostate Cancer: The Disease’s ‘Cell of Origin’ Found
Prostate cancer affects hundreds of thousands of men in the US every year, causing tens of thousands of deaths. A recent finding by researchers at the University of California Los Angeles may have made a discovery that will change that. The Prostate Cancer Foundation reports that the scientists at the UCLA Jonsson Comprehensive Cancer Center have found the ‘cell of origin’, which is the type of ... |
Prostate Cancer: A New Ground Zero
A type of prostate cell that has been largely ignored by cancer researchers can, in fact, trigger malignant prostate cancer, according to new studies by Howard Hughes Medical Institute (HHMI) scientists and their colleagues. HHMI researcher Owen N. Witte and his colleagues at the University of California, Los Angeles (UCLA) found that the somewhat overlooked prostate basal cell can spawn tumors ... |
Prostate Cancer 'Cell of Origin' Identified
For researchers, a key to studying any cancer is finding its "cell of origin." Now scientists at the University of California at Los Angeles say they've found just that -- a specific type of cell that gives rise to prostate cancer. |
Prostate cancer 'cell' identified
A cell that could be the "mother" of all prostate tumours has been identified by scientists. Samples of the "basal" cells taken from healthy human prostate tissue triggered cancer in mice with suppressed immune systems. |
Canines Used To Sniff Out Prostate Cancer
Prostate cancer is the most common cancer in men, with about 1 in 6 affected. Like so many other cancers, catching it early is the key. Now, doctors have discovered a new means of early detection using dogs. |
Cancer Vaccine: 4 Months of Life Worth $100K?
Prostate cancer vaccine, Provenge, adds 4 months to life, at a pricetag of 100K. The first-ever approved cancer vaccine, Provenge offers hope to men with advanced prostate cancer, but the high cost of this new treatment raises healthcare policy questions. Prostate cancer - Sipuleucel-T - Cancer - Cancer vaccine - Health |
Aggressive prostate cancer tend to retain denser bones
Men who develop prostate cancer, especially the more aggressive and dangerous forms that spread throughout the body, tend to retain denser bones as they age than men who stay free of the disease, suggests new research from Johns Hopkins and the National Institute on Aging (NIA), part of the National Institutes of Health. |
|